Advanced Medical Solutions Group’s (AMS) “Buy” Rating Reaffirmed at Berenberg Bank

Advanced Medical Solutions Group (LON:AMS)‘s stock had its “buy” rating reissued by research analysts at Berenberg Bank in a research report issued on Tuesday,Digital Look reports. They presently have a GBX 300 price target on the stock. Berenberg Bank’s price target indicates a potential upside of 37.61% from the company’s current price.

Separately, Royal Bank Of Canada restated a “sector perform” rating and set a GBX 260 price objective on shares of Advanced Medical Solutions Group in a research report on Thursday, April 9th. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of GBX 270.25.

Advanced Medical Solutions Group Trading Up 8.2%

LON:AMS opened at GBX 218 on Tuesday. The company has a quick ratio of 4.58, a current ratio of 2.79 and a debt-to-equity ratio of 31.50. Advanced Medical Solutions Group has a 1-year low of GBX 187 and a 1-year high of GBX 272. The firm has a market capitalization of £472.87 million, a price-to-earnings ratio of 48.23, a price-to-earnings-growth ratio of 5.00 and a beta of 0.72. The stock has a fifty day simple moving average of GBX 218.61 and a 200 day simple moving average of GBX 216.37.

Advanced Medical Solutions Group (LON:AMS) last released its quarterly earnings results on Wednesday, March 18th. The company reported GBX 11.98 earnings per share for the quarter. Advanced Medical Solutions Group had a return on equity of 3.87% and a net margin of 4.35%. Sell-side analysts forecast that Advanced Medical Solutions Group will post 9.8159509 earnings per share for the current year.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.